Clinical Trial Update: In-Home Evaluation of Episodic Administration of Palovarotene in Fibrodysplasia Ossificans Progressiva (FOP) Subjects [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating episodic in-home administration of palovarotene in Fibrodysplasia Ossificans Progressiva has been terminated; results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibrodysplasia Ossificans Progressiva

Drugs mentioned

• Palovarotene (palovarotene)

Snippet

Sponsor: Clementia Pharmaceuticals Inc. | Conditions: Fibrodysplasia Ossificans Progressiva | Phase 2 | Status: TERMINATED | Results posted: 2020-10-19